Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00770666 · ClinicalTrials.gov registry record · Phase 4
Combination Medications vs. Patch Alone for Medically-Ill Smokers
A Phase 4 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 127
- Enrollment target
NCT00770666 is a Phase 4 study that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 127 participants.
The verdict
NCT00770666, a Phase 4 study, has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 127 participants
- Enrollment target
Study Summary
Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6 months in smokers with medical illness
Interventions
- DRUG Nicotine patch
- DRUG Nicotine patch, nicotine inhaler, bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00770666
The ClinicalTrials.gov registry entry for NCT00770666 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine patch is the first listed.
NCT00770666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00770666 about?
NCT00770666 is a clinical study titled "Combination Medications vs. Patch Alone for Medically-Ill Smokers". Randomized clinical trial to evaluate a flexibly-dosed-3-medication combination for up to 6 months in smokers with medical illness
What is the current status of trial NCT00770666?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 127 participants. The study started on 2005-09. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00770666?
The interventions under investigation include: Nicotine patch (DRUG), Nicotine patch, nicotine inhaler, bupropion (DRUG).
Who is sponsoring clinical trial NCT00770666?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.